Hogenhuis Wladimir

Director Hogenhuis buys 5,650 shares of RZLT at $1.69; stock -81.6% from 52-week high amid cluster buy pattern

Hogenhuis Wladimir (Director) purchased 5,650 shares at $1.69 on 2025-12-16, increasing holdings to 119,675 shares (a +5.0% increase). The purchase occurs amid severe price deterioration: RZLT is -81.6% from its 52-week high of $10.94 and -80.3% over the past 30 days. The company is unprofitable with net income of $-18,150,000.00 against a market cap of $186,382,339.32. At the same-ticker level, Hogenhuis's prior four RZLT purchases showed mixed 90-day outcomes (2 profitable, 2 unprofitable), with timing success in only 50% of instances. The transaction occurs within a cluster of 4 other insider buys in the past 14 days, indicating coordinated director-level activity during a period of sharp stock decline. The combination of deep price weakness, unprofitability, and group buying activity warrants investor review of whether insiders view current valuations as compelling or whether broader strategic factors are driving synchronized purchases.

Director Hogenhuis buys 6,758 shares of RZLT at $2.92; stock down 51.0% from 52-week high amid $-15.7M net loss

Director Wladimir Hogenhuis purchased 6,758 shares on 2025-03-31 at $2.92, increasing his holdings by 8.7% to 84,025 shares total. The purchase occurs in a deteriorating price environment: RZLT has fallen 51.0% from its 52-week high and 34.1% over the past 30 days. Rezolute reported a full-year net income of $-15,730,000.00, indicating ongoing unprofitability. Notably, 2 other insiders also bought within the past 14 days, creating a cluster buy pattern. Hogenhuis's prior purchases at RZLT show mixed timing: his 2024 buys generated positive 90-day returns (+15.4% and −5.5%), but his most recent buy on 2025-02-18 has declined 34.3% over 30 days, and his cross-ticker track record shows a 50% win rate at the 90-day horizon.

Director Hogenhuis buys 10,000 shares of RZLT at $4.70 for $47.0K; stock down -22.3% from 52-week high, company unprofitable at -$15.7M net income

Hogenhuis, a director of Rezolute, purchased 10,000 shares at $4.70 on 2025-02-18, increasing his holdings to 77.3K shares. The purchase occurs as RZLT trades -22.3% from its 52-week high of $5.96 and the company posted a full-year net loss of $15.7M against a market cap of $280.3M. Examining his same-ticker history, his prior two purchases at RZLT (Sept 2024 and June 2024) generated divergent 90-day returns: one returned +15.4% while the other declined -5.5%, showing mixed outcomes on this specific security. His broader cross-ticker track record shows 2 prior buys with an average 90-day return of +4.9% and a 50% win rate, offering limited evidence of consistent timing acumen. The current purchase at a depressed price level warrants observation of whether this represents continued conviction at RZLT or a continuation of pattern-less activity at this unprofitable company.

Director Hogenhuis Wladimir buys 4,259 shares of RZLT at $4.70; holdings rise to 41,767 shares (+11.4%), prior buy at this ticker returned +15.4% in 90 days.

Director Hogenhuis Wladimir purchased 4,259 shares at $4.70 on 2024-09-24, increasing holdings by 11.4% to 41,767 shares, representing a $20,017.30 investment. This marks the director's second open-market purchase of RZLT; his prior buy on 2024-06-25 at this same ticker achieved a +15.4% 90-day return, and across his full trading history (1 prior buy on all tickers), his average 90-day return was +15.4% with a 100% win rate. The current stock price of $4.69 is 19.0% below the 52-week high of $5.79 and up 17.2% over the past 90 days. However, the company reported a full-year net loss of $-17,050,000.00 and remains unprofitable, which contextualizes the director's accumulation against underlying operational challenges.

Director Hogenhuis buys 4.8K shares of RZLT at $4.15; stock down 30.7% from high; 3 other insiders also bought in past 14 days

Director Wladimir Hogenhuis purchased 4,815 shares at $4.15 on 2024-06-25, increasing his holdings by 14.7% to 37,508 shares. The purchase occurred as the stock was down 30.7% from its 52-week high of $5.79 but benefiting from near-term momentum (up 57.2% over 90 days). Notably, this transaction is part of a cluster pattern: 3 other insiders also bought within the same 14-day window, suggesting coordinated director-level confidence in the stock's current valuation. The company remains unprofitable (net income of $-17.0M) with a market cap of $160.9M, so buyers are accumulating despite ongoing losses, not in response to a return to profitability.